- Home
- U vs RGEN Comparison
U vs RGEN Comparison
Compare U & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- U
- RGEN
- Stock Information
- Founded
- U 2004
- RGEN 1981
- Country
- U United States
- RGEN United States
- Employees
- U N/A
- RGEN N/A
- Industry
- U Retail: Computer Software & Peripheral Equipment
- RGEN Medical/Dental Instruments
- Sector
- U Technology
- RGEN Health Care
- Exchange
- U Nasdaq
- RGEN Nasdaq
- Market Cap
- U 7.7B
- RGEN 8.0B
- IPO Year
- U 2020
- RGEN N/A
- Fundamental
- Price
- U $21.52
- RGEN $128.04
- Analyst Decision
- U Buy
- RGEN Buy
- Analyst Count
- U 13
- RGEN 12
- Target Price
- U $23.79
- RGEN $172.67
- AVG Volume (30 Days)
- U 8.5M
- RGEN 830.2K
- Earning Date
- U 05-07-2025
- RGEN 04-29-2025
- Dividend Yield
- U N/A
- RGEN N/A
- EPS Growth
- U N/A
- RGEN N/A
- EPS
- U N/A
- RGEN N/A
- Revenue
- U $1,787,875,000.00
- RGEN $650,429,000.00
- Revenue This Year
- U N/A
- RGEN $13.93
- Revenue Next Year
- U $9.92
- RGEN $14.35
- P/E Ratio
- U N/A
- RGEN N/A
- Revenue Growth
- U N/A
- RGEN 4.88
- 52 Week Low
- U $13.90
- RGEN $102.97
- 52 Week High
- U $30.88
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- U 53.80
- RGEN 44.98
- Support Level
- U $19.81
- RGEN $123.10
- Resistance Level
- U $22.20
- RGEN $135.47
- Average True Range (ATR)
- U 0.99
- RGEN 6.85
- MACD
- U 0.07
- RGEN -0.74
- Stochastic Oscillator
- U 59.23
- RGEN 19.54
About U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.